On ECHEMI
Home > Drugs > Honz Pharmaceutical Co., Ltd.
Honz Pharmaceutical Co., Ltd.
  • Founded in:

    1994-01-20
  • Country:

    China China
  • Address:

    No. 6, Yaogu 3rd Road, Yaogu Industrial Park, Haikou National High-tech Industrial Development Zone, Hainan Province
  • Tax NO.:

    91460000708873536T
  • Registered Funds:

    455.124411 yuan
  • Website:

  • Email:

Related Drugs
Azithromycin for injection
Main ingredients: The main ingredient of this product is azithromycin. Its chemical name is (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-beta;-D-xyl-pyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one. Structural formula: (see azithromycin dry suspension) Molecular formula: C38H72N2O12 Molecular weight: 749
Name Description Content CAS NO. Registered Holders
Azithromycin

Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains.

More

Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains.

83905-01-5 39
Cefoperazone Sodium and Sulbactam Sodium for Injection
This product is a compound preparation, its components are 0.5g each of cefoperazone sodium and sulbactam sodium.
Name Description Content CAS NO. Registered Holders
Cefoperazone sodium

It has good antibacterial effect on Escherichia coli, Klebsiella, Proteus, Salmonella typhi, Shigella, Citrobacter and other Enterobacteriaceae and Pseudomonas aeruginosa. Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis are highly sensitive to it. It also has good effect on various groups of streptococci and pneumococci, and only has moderate effect on Staphylococcus aureus (methicillin-sensitive strain). It mainly inhibits the synthesis of bacterial cell wall.

More

It has good antibacterial effect on Escherichia coli, Klebsiella, Proteus, Salmonella typhi, Shigella, Citrobacter and other Enterobacteriaceae and Pseudomonas aeruginosa. Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis are highly sensitive to it. It also has good effect on various groups of streptococci and pneumococci, and only has moderate effect on Staphylococcus aureus (methicillin-sensitive strain). It mainly inhibits the synthesis of bacterial cell wall.

0.5g 62893-20-3 23
Sulbactam sodium

It has a weak antibacterial effect itself and is a competitive, irreversible beta-lactamase inhibitor. When used in combination with cefoperazone, it can increase the ability of cefoperazone to resist degradation by various beta-lactamases and produce a significant synergistic effect on cefoperazone.

More

It has a weak antibacterial effect itself and is a competitive, irreversible beta-lactamase inhibitor. When used in combination with cefoperazone, it can increase the ability of cefoperazone to resist degradation by various beta-lactamases and produce a significant synergistic effect on cefoperazone.

0.5g 69388-84-7 30
Cefoperazone Sodium and Sulbactam Sodium for Injection
This product is a compound preparation, its components are 0.5g each of cefoperazone sodium and sulbactam sodium.
Name Description Content CAS NO. Registered Holders
Cefoperazone sodium

It has good antibacterial effect on Escherichia coli, Klebsiella, Proteus, Salmonella typhi, Shigella, Citrobacter and other Enterobacteriaceae and Pseudomonas aeruginosa. Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis are highly sensitive to it. It also has good effect on various groups of streptococci and pneumococci, and only has moderate effect on Staphylococcus aureus (methicillin-sensitive strains). It has good effect on most Gram-positive anaerobes and some Gram-negative anaerobes. It mainly inhibits the synthesis of bacterial cell walls.

More

It has good antibacterial effect on Escherichia coli, Klebsiella, Proteus, Salmonella typhi, Shigella, Citrobacter and other Enterobacteriaceae and Pseudomonas aeruginosa. Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis are highly sensitive to it. It also has good effect on various groups of streptococci and pneumococci, and only has moderate effect on Staphylococcus aureus (methicillin-sensitive strains). It has good effect on most Gram-positive anaerobes and some Gram-negative anaerobes. It mainly inhibits the synthesis of bacterial cell walls.

0.5g 62893-20-3 23
Sulbactam sodium

It has a weak antibacterial effect itself and is a competitive, irreversible beta-lactamase inhibitor. When used in combination with cefoperazone, it can increase the ability of cefoperazone to resist degradation by various beta-lactamases and produce a significant synergistic effect on cefoperazone.

More

It has a weak antibacterial effect itself and is a competitive, irreversible beta-lactamase inhibitor. When used in combination with cefoperazone, it can increase the ability of cefoperazone to resist degradation by various beta-lactamases and produce a significant synergistic effect on cefoperazone.

0.5g 69388-84-7 30
New Houttuynia cordata Sodium for Injection
The active ingredient of Houttuynia cordata is sodium bisulfite of dodecyl acetaldehyde.
Name Description Content CAS NO. Registered Holders
Sodium bisulfite of dodecanoyl acetaldehyde

1. Antibacterial effect: It has obvious inhibitory effect on Staphylococcus aureus, influenza bacillus, and pneumococcus; 2. Antiviral effect: It has inhibitory effect on many viruses; 3. It can improve the body's immunity, enhance the phagocytic ability of white blood cells, and enhance the body's non-specific immune ability; 4. It has diuretic, anti-allergic, and anti-asthmatic effects

More

1. Antibacterial effect: It has obvious inhibitory effect on Staphylococcus aureus, influenza bacillus, and pneumococcus; 2. Antiviral effect: It has inhibitory effect on many viruses; 3. It can improve the body's immunity, enhance the phagocytic ability of white blood cells, and enhance the body's non-specific immune ability; 4. It has diuretic, anti-allergic, and anti-asthmatic effects

0
New Houttuynia cordata Sodium for Injection
The active ingredient of Houttuynia cordata is sodium bisulfite of dodecyl acetaldehyde.
Name Description Content CAS NO. Registered Holders
Sodium bisulfite of dodecanoyl acetaldehyde

1. Antibacterial effect: has obvious inhibitory effect on Staphylococcus aureus, influenza bacillus, and pneumococcus; 2. Antiviral effect: has inhibitory effect on many viruses; 3. Improve the body's immunity: can enhance the phagocytic ability of white blood cells and enhance the body's non-specific immune ability; 4. Has diuretic, anti-allergic, and anti-asthmatic effects

More

1. Antibacterial effect: has obvious inhibitory effect on Staphylococcus aureus, influenza bacillus, and pneumococcus; 2. Antiviral effect: has inhibitory effect on many viruses; 3. Improve the body's immunity: can enhance the phagocytic ability of white blood cells and enhance the body's non-specific immune ability; 4. Has diuretic, anti-allergic, and anti-asthmatic effects

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.